InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Explore the detailed record of transactions filed by Duhay Francis, Director. Officer active across 1 companies, notably Hancock Jaffe Laboratories, Inc.. Cumulatively, 2 disclosures have been published. Total volume traded: €83k. The latest transaction was filed on 17 May 2021 (Acquisition). Regulator: SEC (Form 4). The full history is openly available.
Declarations2 total
€41,6169,492 shares@ €4.3844100.0% of flow
Common Stock, $$0.00001 par value
SEC:0001493152-21-012296·
Ideal exit: 11 Feb 2022 (T+270)
€41,6169,492 shares@ €4.384450.0% of flow
Common Stock, $$0.00001 par value
SEC:0001493152-21-012296:0·
Ideal exit: 11 Feb 2022 (T+270)
2 of 2 declarations
About Duhay Francis
Francis Duhay is a Director at Hancock Jaffe Laboratories, Inc. In this role, he contributes to the governance and strategy of the company. Hancock Jaffe Laboratories, Inc. is a company specializing in the development of medical devices. Francis Duhay brings valuable expertise in medical technology and innovation.
